---
figid: PMC7788038__12249_2020_1897_Fig5_HTML
figlink: pmc/articles/PMC7788038/figure/Fig5/
number: Fig. 5
caption: Schematic diagram of the possible mechanisms of action allowing n-3 polyunsaturated
  fatty acids to act in synergy with 5-fluorouracil on cancer cells. While 5-fluorouracil
  induces cell cycle arrest and pyrimidine misincorporation into DNA, eicosapentaenoic
  acid and docosahexaenoic acid hamper inflammation, angiogenesis, and cell migration
  through competitive inhibition of cyclooxygenase II metabolic pathway and induce
  DNA damage and cell membrane disruption through their peroxidation products. COX-2,
  cyclooxygenase II; DHF, dihydrofolate; dTTP, thymidine triphosphate; dUMP, deoxyuridine
  monophosphate; EGFR, epidermal growth factor receptor; 4-HNE, 4-hydroxynonenal;
  MDA, malondialdehyde; M1G, pyrimido[1,2-a]purin-10(3H)-one; MTHF, methyltetrahydrofolate;
  PGE2, prostaglandin E2; THF, tetrahydrofolate; VEGF, vascular endothelial growth
  factor
pmcid: PMC7788038
papertitle: Antitumor Effect of 5-Fluorouracil-Loaded Liposomes Containing n-3 Polyunsaturated
  Fatty Acids in Two Different Colorectal Cancer Cell Lines.
reftext: Yves Marc Dupertuis, et al. AAPS PharmSciTech. 2021 Jan;22(1):36.
pmc_ranked_result_index: '7672'
pathway_score: 0.9538659
filename: 12249_2020_1897_Fig5_HTML.jpg
figtitle: Possible mechanisms of action allowing n-3 polyunsaturated fatty acids to
  act in synergy with 5-fluorouracil on cancer cells
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7788038__12249_2020_1897_Fig5_HTML.html
  '@type': Dataset
  description: Schematic diagram of the possible mechanisms of action allowing n-3
    polyunsaturated fatty acids to act in synergy with 5-fluorouracil on cancer cells.
    While 5-fluorouracil induces cell cycle arrest and pyrimidine misincorporation
    into DNA, eicosapentaenoic acid and docosahexaenoic acid hamper inflammation,
    angiogenesis, and cell migration through competitive inhibition of cyclooxygenase
    II metabolic pathway and induce DNA damage and cell membrane disruption through
    their peroxidation products. COX-2, cyclooxygenase II; DHF, dihydrofolate; dTTP,
    thymidine triphosphate; dUMP, deoxyuridine monophosphate; EGFR, epidermal growth
    factor receptor; 4-HNE, 4-hydroxynonenal; MDA, malondialdehyde; M1G, pyrimido[1,2-a]purin-10(3H)-one;
    MTHF, methyltetrahydrofolate; PGE2, prostaglandin E2; THF, tetrahydrofolate; VEGF,
    vascular endothelial growth factor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - EGFR
  - Eicosapentaenoic acid
  - Doxosahexahenoic acid
  - Hydroperoxides
  - Carbonyl
  - 5-Fluorouracil
  - Arachidonic acid
  - PGE
genes:
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
chemicals:
- word: Eicosapentaenoic acid
  source: MESH
  identifier: D015118
- word: Doxosahexahenoic acid
  source: MESH
  identifier: D000596
- word: Hydroperoxides
  source: MESH
  identifier: D006861
- word: Carbonyl
  source: MESH
  identifier: C548957
- word: 5-Fluorouracil
  source: MESH
  identifier: D005472
- word: Arachidonic acid
  source: MESH
  identifier: D001095
- word: PGE
  source: MESH
  identifier: D011458
diseases: []
---
